490 related articles for article (PubMed ID: 15563313)
1. Vasculogenic mimicry.
Folberg R; Maniotis AJ
APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
[TBL] [Abstract][Full Text] [Related]
2. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
[TBL] [Abstract][Full Text] [Related]
4. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
Hendrix MJ; Seftor EA; Hess AR; Seftor RE
Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
[TBL] [Abstract][Full Text] [Related]
5. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
Sun B; Zhang S; Zhao X; Zhang W; Hao X
Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
[TBL] [Abstract][Full Text] [Related]
6. Vasculogenic mimicry: current status and future prospects.
Zhang S; Zhang D; Sun B
Cancer Lett; 2007 Sep; 254(2):157-64. PubMed ID: 17306454
[TBL] [Abstract][Full Text] [Related]
7. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
8. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
9. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
Bhat P; Jakobiec FA; Folberg R
Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
[TBL] [Abstract][Full Text] [Related]
11. Microcirculation patterns in different stages of melanoma growth.
Zhang S; Guo H; Zhang D; Zhang W; Zhao X; Ren Z; Sun B
Oncol Rep; 2006 Jan; 15(1):15-20. PubMed ID: 16328029
[TBL] [Abstract][Full Text] [Related]
12. Vasculogenic mimicry and tumor angiogenesis.
Folberg R; Hendrix MJ; Maniotis AJ
Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of vasculogenic mimicry in colorectal cancer.
Baeten CI; Hillen F; Pauwels P; de Bruine AP; Baeten CG
Dis Colon Rectum; 2009 Dec; 52(12):2028-35. PubMed ID: 19934926
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
15. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
Hess AR; Seftor EA; Seftor RE; Hendrix MJ
Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
[TBL] [Abstract][Full Text] [Related]
17. The involvement of apoptosis in melanoma vasculogenic mimicry.
Vartanian AA; Burova OS; Stepanova EV; Baryshnikov AY
Melanoma Res; 2007 Feb; 17(1):1-8. PubMed ID: 17235236
[TBL] [Abstract][Full Text] [Related]
18. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography.
Frenkel S; Barzel I; Levy J; Lin AY; Bartsch DU; Majumdar D; Folberg R; Pe'er J
Eye (Lond); 2008 Jul; 22(7):948-52. PubMed ID: 17363922
[TBL] [Abstract][Full Text] [Related]
19. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.
Hess AR; Margaryan NV; Seftor EA; Hendrix MJ
Dev Dyn; 2007 Dec; 236(12):3283-96. PubMed ID: 17557303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]